Target intelligence / Profile preview

Dehydrodolichyl diphosphate synthase subunit (DHDDS)

Target
DHDDS
Molecular classification
Enzyme, Prenyltransferase (specifically cis-prenyltransferase), Transferase (condenses isopentenyl diphosphate with farnesyl diphosphate)
01

Overview

Dehydrodolichyl diphosphate synthase subunit (DHDDS) is a highly conserved enzyme and the catalytic core of the human cis-prenyltransferase complex. DHDDS catalyzes cis-prenyl chain elongation by joining isopentenyl diphosphate and farnesyl diphosphate, producing the polyisoprenoid backbone of dolichol, a lipid essential for protein N-glycosylation in the ER. The enzymatic activity and substrate specificity require heteromerization with the Nogo-B receptor (NgBR). DHDDS mutations disrupt dolichol synthesis and are causally associated with diseases like autosomal recessive retinitis pigmentosa and developmental epileptic encephalopathies, emphasizing its central role in human metabolism and disease.

Other names
Dehydrodolichyl diphosphate synthaseDHDDSHDSCITCis-isoprenyltransferaseCis-prenyltransferase subunit hCITDSRP59hCITEpididymis tissue protein Li 189mCPTDEDSMdedol-PP synthase
02

Mechanism of action

not applicable (no approved drugs); theoretical mechanism would be enzyme inhibition, blocking dolichol synthesis

03

Biological functions

Polyisoprenoid biosynthesis (dolichol)N-linked protein glycosylationCellular membrane biology
04

Disease associations

Retinitis pigmentosa (autosomal recessive)Developmental epileptic encephalopathiesOther congenital glycosylation disorders
05

Safety considerations

Essential for cell viability; inhibition may cause severe glycosylation defects and toxicity
06

Biomarkers

DHDDS genetic mutations (e.g., Lys42Glu) for inherited retinal degeneration and epilepsy

Beyond the preview

Go deeper on Dehydrodolichyl diphosphate synthase subunit (DHDDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dehydrodolichyl diphosphate synthase subunit (DHDDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call